| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |